Experiencing Memory Loss?

Memory loss is more common than any of us would like to admit—and watching someone you love experience memory problems can make you feel helpless. By participating in a clinical study, you or your loved one can help to reshape Alzheimer’s treatment, helping scientists better understand how it affects the brain.

Find Out How

How It Works

The path to participating is simple.

Complete The Survey

Answer eight easy questions, and we’ll let you know whether or not you or your loved one may be eligible to participate in the study.

Schedule An Appointment

If you or a loved one qualify, the next step is speaking with an expert. Find 15 minutes that work for you, and we’ll get you connected.

Speak To An Expert

We are here to help. Our dedicated experts understand your situation and will listen, answer any questions, and address concerns.

Who can participate?

To join the INTERCEPT-AD (ACU-001) study, participants must meet the following qualifications.

  • Be 55 to 90 years old
  • Be experiencing memory problems and may or may not have been diagnosed with mild cognitive impairment or Alzheimer’s disease
  • Have a caregiver or partner willing to assist with participation in the study and who can attend study visits with the participant

Read more about our participation requirements to see if you or your loved one are a good fit.

Experience Innovation

Help Yourself

Help Others

Shape The Future

Clinical Trials Make A Difference

When you participate in a clinical study, you provide valuable information that could eventually lead to better treatment, and—with the right breakthrough—better outcomes. Take our short eight question survey to see if you or your loved one are a good fit. There is no obligation.

Take The Survey

Frequently Asked Questions

Visit FAQ Page >
What are the symptoms of memory loss?

Signs of mild cognitive impairment (MCI) or memory loss may include:

  • Losing things often
  • Difficulty finding the words
  • Forgetting to attend important events
  • Trouble reading, writing, or holding a conversation
  • Repeating the same questions or stories
  • Feeling lost in familiar places
  • Neglecting to pay bills
Who should apply?

You should consider applying, or apply for a loved one, if you or your loved one are

  • Experiencing signs of memory loss and may or may not have been diagnosed with mild cognitive impairment or Alzheimer’s disease
  • Between 55 and 90 years old
  • Have a caregiver or partner willing to assist with participation in the study and who can attend study visits with the participant
  • See more requirements here
What are the benefits?

The information learned from the study may help find new treatment options in the future for people with memory problems who are then diagnosed with mild cognitive impairment or Alzheimer’s disease. Study participants will receive a full diagnostic work-up, including amyloid PET scan and MRI, which can help determine if memory loss is due to early Alzheimer’s disease. Plus, completing this study may qualify you to participate in future studies, where you or your loved one could receive ACU193.

Are there any risks to participating?

This study is the first time ACU193 will be given to people. As all drugs and medical procedures carry a risk of side effects, it is possible that participants may experience some discomfort or other reactions. The study staff will explain these potential risks before participants decide whether to participate in the study.

What will happen during the study?

Participants who meet all study requirements will be randomly assigned to receive one to three doses of either ACU193 or placebo. The placebo has no active medication. In total, this study will involve 8-11 visits over a period of about 8 months. Some participants may stay overnight at the study center for 2 to 4 nights. During the visits, participants will have a safe, caring environment so caregivers can feel confident their loved ones are being treated with kindness and respect.

What are the costs?

There is no cost to participate. Qualified participants do not pay for the study medication, clinic visits, overnight stays, or study-related medical procedures and laboratory tests. Participants will be compensated for the clinic visits they complete.

For additional questions, contact us anytime at chloe.jones@iresearchatlanta.com.

A BETTER PATH FORWARD

Worried About Memory Loss?

Many people worry when they or someone they love start to experience memory problems. Participating in the INTERCEPT-AD (ACU-001) study can give you or your loved one access to experts who understand your situation and can help answer your questions.